• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全基因组分析鉴定的功能疾病因果/易感变异在理解人类疾病中的意义。

Significance of functional disease-causal/susceptible variants identified by whole-genome analyses for the understanding of human diseases.

机构信息

Department of Human Genetics, Graduate School of Medicine, the University of Tokyo.

出版信息

Proc Jpn Acad Ser B Phys Biol Sci. 2017;93(9):657-676. doi: 10.2183/pjab.93.042.

DOI:10.2183/pjab.93.042
PMID:29129848
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5743846/
Abstract

Human genome variation may cause differences in traits and disease risks. Disease-causal/susceptible genes and variants for both common and rare diseases can be detected by comprehensive whole-genome analyses, such as whole-genome sequencing (WGS), using next-generation sequencing (NGS) technology and genome-wide association studies (GWAS). Here, in addition to the application of an NGS as a whole-genome analysis method, we summarize approaches for the identification of functional disease-causal/susceptible variants from abundant genetic variants in the human genome and methods for evaluating their functional effects in human diseases, using an NGS and in silico and in vitro functional analyses. We also discuss the clinical applications of the functional disease causal/susceptible variants to personalized medicine.

摘要

人类基因组变异可能导致性状和疾病风险的差异。通过综合全基因组分析,如使用下一代测序 (NGS) 技术的全基因组测序 (WGS) 和全基因组关联研究 (GWAS),可以检测到常见和罕见疾病的致病/易感基因和变异。在这里,除了将 NGS 作为一种全基因组分析方法的应用外,我们还总结了从人类基因组中丰富的遗传变异中鉴定功能疾病因果/易感变异的方法,以及使用 NGS 以及体内和体外功能分析评估其在人类疾病中的功能效应的方法。我们还讨论了功能疾病因果/易感变异在个性化医疗中的临床应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a9c/5743846/e75e279b2bb7/pjab-93-657-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a9c/5743846/4167efaa6a40/pjab-93-657-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a9c/5743846/e75e279b2bb7/pjab-93-657-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a9c/5743846/4167efaa6a40/pjab-93-657-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a9c/5743846/e75e279b2bb7/pjab-93-657-g002.jpg

相似文献

1
Significance of functional disease-causal/susceptible variants identified by whole-genome analyses for the understanding of human diseases.全基因组分析鉴定的功能疾病因果/易感变异在理解人类疾病中的意义。
Proc Jpn Acad Ser B Phys Biol Sci. 2017;93(9):657-676. doi: 10.2183/pjab.93.042.
2
Opportunities and challenges of whole-genome and -exome sequencing.全基因组和外显子组测序的机遇与挑战
BMC Genet. 2017 Feb 14;18(1):14. doi: 10.1186/s12863-017-0479-5.
3
Clinical pharmacogenomics testing in the era of next generation sequencing: challenges and opportunities for precision medicine.临床药物基因组学检测在下一代测序时代:精准医学的挑战和机遇。
Expert Rev Mol Diagn. 2018 May;18(5):411-421. doi: 10.1080/14737159.2018.1461561. Epub 2018 Apr 23.
4
Next-generation diagnostics: gene panel, exome, or whole genome?下一代诊断技术:基因组合、外显子组还是全基因组?
Hum Mutat. 2015 Jun;36(6):648-55. doi: 10.1002/humu.22783. Epub 2015 Apr 17.
5
Next generation sequencing: implications in personalized medicine and pharmacogenomics.下一代测序:在个性化医疗和药物基因组学中的意义。
Mol Biosyst. 2016 May 24;12(6):1818-30. doi: 10.1039/c6mb00115g.
6
Lake Louise mutation detection meeting 2013: clinical translation of next-generation sequencing requires optimization of workflows and interpretation of variants.2013 年路易斯湖突变检测会议:下一代测序的临床转化需要优化工作流程和变异解释。
Hum Mutat. 2014 Feb;35(2):265-9. doi: 10.1002/humu.22480. Epub 2013 Nov 27.
7
Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants.在检测外显子变异方面,全基因组测序比全外显子测序更强大。
Proc Natl Acad Sci U S A. 2015 Apr 28;112(17):5473-8. doi: 10.1073/pnas.1418631112. Epub 2015 Mar 31.
8
A novel knowledge-derived data potentizing method revealed unique liver cancer-associated genetic variants.一种新颖的基于知识的数据增强方法揭示了独特的肝癌相关遗传变异。
Hum Genomics. 2019 Jul 4;13(1):30. doi: 10.1186/s40246-019-0213-7.
9
Whole-Genome Sequencing of a Canine Family Trio Reveals a FAM83G Variant Associated with Hereditary Footpad Hyperkeratosis.一个犬类三联体家族的全基因组测序揭示了一个与遗传性脚垫角化过度相关的FAM83G变体。
G3 (Bethesda). 2016 Jan 8;6(3):521-7. doi: 10.1534/g3.115.025643.
10
Controversy and debate on clinical genomics sequencing-paper 1: genomics is not exceptional: rigorous evaluations are necessary for clinical applications of genomic sequencing.关于临床基因组测序的争议与辩论——论文1:基因组学并非特例:基因组测序临床应用需要严格评估。
J Clin Epidemiol. 2017 Dec;92:4-6. doi: 10.1016/j.jclinepi.2017.08.018. Epub 2017 Sep 1.

引用本文的文献

1
Technological Improvements in the Genetic Diagnosis of Rett Syndrome Spectrum Disorders.技术进步在雷特综合征谱系障碍的基因诊断中的应用。
Int J Mol Sci. 2021 Sep 26;22(19):10375. doi: 10.3390/ijms221910375.

本文引用的文献

1
Genome-wide association studies identify PRKCB as a novel genetic susceptibility locus for primary biliary cholangitis in the Japanese population.全基因组关联研究确定PRKCB是日本人群原发性胆汁性胆管炎的一个新的遗传易感性位点。
Hum Mol Genet. 2017 Feb 1;26(3):650-659. doi: 10.1093/hmg/ddw406.
2
CRISPR/Cas9 Targeted Gene Editing and Cellular Engineering in Fanconi Anemia.范可尼贫血中的CRISPR/Cas9靶向基因编辑与细胞工程
Stem Cells Dev. 2016 Oct;25(20):1591-1603. doi: 10.1089/scd.2016.0149. Epub 2016 Aug 18.
3
Exome Genotyping Identifies Pleiotropic Variants Associated with Red Blood Cell Traits.
外显子基因分型鉴定出与红细胞性状相关的多效性变异。
Am J Hum Genet. 2016 Jul 7;99(1):8-21. doi: 10.1016/j.ajhg.2016.05.007. Epub 2016 Jun 23.
4
SAMD9 mutations cause a novel multisystem disorder, MIRAGE syndrome, and are associated with loss of chromosome 7.SAMD9 突变导致一种新的多系统疾病,MIRAGE 综合征,并与 7 号染色体缺失有关。
Nat Genet. 2016 Jul;48(7):792-7. doi: 10.1038/ng.3569. Epub 2016 May 16.
5
Hepatitis C-A clinical review.丙型肝炎的临床综述。
J Med Virol. 2016 Nov;88(11):1844-55. doi: 10.1002/jmv.24554. Epub 2016 Apr 29.
6
Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer.肝癌全基因组突变全景及非编码区和结构突变特征。
Nat Genet. 2016 May;48(5):500-9. doi: 10.1038/ng.3547. Epub 2016 Apr 11.
7
Ultra-sensitive droplet digital PCR for detecting a low-prevalence somatic GNAQ mutation in Sturge-Weber syndrome.用于检测斯特奇-韦伯综合征中低流行率体细胞GNAQ突变的超灵敏液滴数字PCR
Sci Rep. 2016 Mar 9;6:22985. doi: 10.1038/srep22985.
8
In vivo gene editing in dystrophic mouse muscle and muscle stem cells.营养不良小鼠肌肉和肌肉干细胞中的体内基因编辑。
Science. 2016 Jan 22;351(6271):407-411. doi: 10.1126/science.aad5177. Epub 2015 Dec 31.
9
In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy.体内基因组编辑改善了杜兴氏肌肉营养不良小鼠模型的肌肉功能。
Science. 2016 Jan 22;351(6271):403-7. doi: 10.1126/science.aad5143. Epub 2015 Dec 31.
10
Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy.产后基因编辑可部分恢复肌营养不良小鼠模型中的肌营养不良蛋白表达。
Science. 2016 Jan 22;351(6271):400-3. doi: 10.1126/science.aad5725. Epub 2015 Dec 31.